Department of Prosthodontics, Faculty of Dentistry, Jordan University of Science and Technology, Irbid, Jordan.
Department of Applied Dental Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan.
Medicine (Baltimore). 2024 Oct 4;103(40):e39923. doi: 10.1097/MD.0000000000039923.
Obstructive sleep apnea (OSA) is caused by narrowing or obstruction of the airway lumen at single or multiple levels of the airway, starting from the nasal cavity up to the larynx. Oral appliance therapy for the management of OSA is prescribed as an alternative treatment option for patients with mild to moderate OSA who fail to adhere to Continuous Positive Airway Pressure (CPAP) therapy. Treatment with oral appliances addresses the craniofacial deficiencies that cause OSA by providing means to mandibular advancement and palatal expansion, thus opening the airways and potentially preventing airway collapse during sleep. Imaging the upper airway is employed to investigate the narrowing or the obstruction in the airway. Three-dimensional imaging modalities such as cone beam computed tomography (CBCT) allow for detecting obstructions before commencing treatment and for evaluating changes in the upper airway dimensions after treatment. To evaluate the effect of the biomimetic oral appliance therapy (BOAT) device on the airway measurements taken from a CBCT before and after treatment in correlation with the changes in the AHI.
A non-randomized clinical trial.
About 17 patients with mild-moderate OSA (9 males, 8 females; age, mean [SD]: 45.76 [10.31]) underwent BOAT therapy. Subjects had 2 months of follow-up visits, including examinations for progress and adjustment of the appliances. The mean apnea-hypopnea index (AHI) with no appliance in the mouth before BOAT and after treatment was recorded. The midpalate screw mechanism of the appliance was advanced once per week. The subjects were asked to wear the appliance for 10 to 12 h/d and night. Pre and Post CBCT were taken. Paired T-test was used to analyze the results.
The treatment duration was 15.4 ± 6.3 months. Before treatment, at the diagnosis stage, the mean AHI of the sample (n = 17) was 24.0. After treatment, the mean AHI fell by 5% to 22.8% (P = .019), indicating enhanced upper airway functions. Airway measurements from the CBCT were not statistically significant despite improvement in the polysomnographic parameters.
CBCT is a valuable tool for airway assessment and the determination of upper airway anatomic risk factors for OSA.
阻塞性睡眠呼吸暂停(OSA)是由气道腔在气道的一个或多个水平的狭窄或阻塞引起的,从鼻腔向上延伸至喉部。口腔矫治器治疗是一种替代疗法,适用于轻度至中度 OSA 患者,这些患者无法坚持持续气道正压通气(CPAP)治疗。口腔矫治器治疗通过提供下颌前伸和腭扩张的手段来治疗导致 OSA 的颅面缺陷,从而打开气道并在睡眠期间潜在地防止气道塌陷。对气道进行成像可用于检查气道的狭窄或阻塞。锥形束计算机断层扫描(CBCT)等三维成像方式可在开始治疗前检测阻塞,并在治疗后评估上气道尺寸的变化。为了评估仿生口腔矫治器治疗(BOAT)设备对气道测量值的影响,从治疗前后的 CBCT 中进行评估,并与 AHI 的变化相关联。
非随机临床试验。
约 17 名轻度至中度 OSA 患者(9 名男性,8 名女性;年龄,均值[标准差]:45.76[10.31])接受了 BOAT 治疗。患者进行了 2 个月的随访,包括检查进展情况和调整矫治器。在 BOAT 治疗前和治疗后无矫治器时记录平均呼吸暂停低通气指数(AHI)。矫治器的中切牙螺丝机制每周推进一次。要求患者每天佩戴矫治器 10 至 12 小时,并在夜间佩戴。进行了治疗前后的 CBCT 检查。采用配对 T 检验对结果进行分析。
治疗持续时间为 15.4±6.3 个月。在治疗前的诊断阶段,样本(n=17)的平均 AHI 为 24.0。治疗后,平均 AHI 下降 5%至 22.8%(P=0.019),表明上气道功能增强。尽管睡眠多导图参数有所改善,但 CBCT 气道测量值没有统计学意义。
CBCT 是评估气道和确定 OSA 上气道解剖危险因素的有价值的工具。